Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease

The discouraging results with therapies for Alzheimer’s disease (AD) in clinical trials, highlights the urgent need to adopt new approaches. Like other complex diseases, it is becoming clear that AD therapies should focus on the simultaneous modulation of several targets implicated in the disease. R...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Aging Neurosci
Main Authors: Cuadrado-Tejedor, Mar, Pérez-González, Marta, García-Muñoz, Cristina, Muruzabal, Damián, García-Barroso, Carolina, Rabal, Obdulia, Segura, Víctor, Sánchez-Arias, Juan A., Oyarzabal, Julen, Garcia-Osta, Ana
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6597953/
https://ncbi.nlm.nih.gov/pubmed/31281249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2019.00149
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados